Search Result "arimoclomol"
Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 31 Year: 2014 Page: 3583-3593
Author(s): G. Yacila,Y. Sari
Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 6 Year: 2010 Page: 779-790
Author(s): Daryl A. Bosco, John E. Landers
Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 309-346
Author(s): Tim Crul,Noemi Toth,Stefano Piotto,Peter Literati-Nagy,Kalman Tory,Pierre Haldimann,Bernadett Kalmar,Linda Greensmith,Zsolt Torok,Gabor Balogh,Imre Gombos,Federica Campana,Simona Concilio,Ferenc Gallyas,Gabor Nagy,Zoltan Berente,Burcin Gungor,Maria Peter,Attila Glatz,Akos Hunya,Zsuzsanna Literati-Nagy,Laszlo Vigh,Femke Hoogstra-Berends,Andre Heeres,Irma Kuipers,Lizette Loen,Jean-Paul Seerden,Deli Zhang,Roelien A M Meijering,Robert H Henning,Bianca J J M Brundel,Harm H Kampinga,Laszlo Koranyi,Zoltan Szilvassy,Jozsef Mandl,Balazs Sumegi,Mark A Febbraio,Ibolya Horvath,Philip L Hooper,Laszlo Vigh
Update on Myositis Therapy: From Todayâs Standards to Tomorrowâs Possibilities
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 11 Year: 2022 Page: 863-880
Author(s): Stefanie Glaubitz,Rachel Zeng,Goran Rakocevic,Jens Schmidt
Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases
Journal: Current Pharmaceutical Biotechnology
Volume: 11 Issue: 2 Year: 2010 Page: 158-166
Author(s): Shigeki Arawaka, Youhei Machiya, Takeo Kato
Clinical Trials for Neuroprotection in ALS
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 3 Year: 2010 Page: 305-313
Author(s): G. Siciliano, C. Carlesi, L. Pasquali, S. Piazza, S. Pietracupa, F. Fornai, S. Ruggieri, L. Murri
Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Journal: Current Pharmaceutical Biotechnology
Volume: 11 Issue: 2 Year: 2010 Page: 198-215
Author(s): M. U. Sajjad, B. Samson, A. Wyttenbach
The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3028-3034
Author(s): V. Palomo, D. I. Perez, C. Gil, A. Martinez
Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 6 Year: 2010 Page: 741-753
Author(s): S. K. Kalia, L. V. Kalia, P. J. McLean
Drug Targets from Genetics: Alpha-Synuclein
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 712-723
Author(s): Karin M. Danzer, Pamela J. McLean